Literature DB >> 27825101

Dynamic contributions of P- and E-selectins to β2-integrin-induced neutrophil transmigration.

Yixin Gong1,2,3, Yan Zhang1,2,3,4, Shiliang Feng1,2,3, Xiaofeng Liu1,2,3, Shouqin Lü1,2,3,4, Mian Long5,2,3,4.   

Abstract

Leukocyte transendothelial migration is a key step in their recruitment to sites of inflammation. However, synergic regulation of endothelium-expressed selectins on leukocyte transmigration remains unclear. In this study, an in vitro model was developed to investigate the dynamic contributions of P- and E-selectin to polymorphonuclear neutrophil (PMN) transmigration under static conditions. Human umbilical vein endothelial cells (HUVECs) were treated with LPS for 4 or 12 h to induce different expression of selectins and intercellular adhesion molecule (ICAM)-1. PMN transmigration was increased significantly by LPS stimulation, which was higher on 4-h than on 12-h LPS-treated HUVECs. Blocking and competitive tests indicated that P-selectin engages PSGL-1 to activate β2-integrin and initiate PMN transmigration within the first 15 min, whereas E-selectin engages CD44 to influence PMN transmigration after 15 min. P- and E-selectin-induced β2-integrin activation is likely conducted through the spleen tyrosine kinase signaling pathway. Complicated complementary and competitive mechanisms are involved in the interaction of P-/E-selectins and their ligands to promote PMN transmigration. These results provide direct evidence of the distinct and dynamic contribution of P- and E-selectins in mediating PMN transmigration and give new insight into PMN interaction with the vessel wall.-Gong, Y., Zhang, Y., Feng, S., Liu, X., Lü, S., Long, M. Dynamic contributions of P- and E-selectins to β2-integrin-induced neutrophil transmigration. © FASEB.

Entities:  

Keywords:  CD44; PSGL-1; synergic mechanisms

Mesh:

Substances:

Year:  2016        PMID: 27825101     DOI: 10.1096/fj.201600398RRR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  8 in total

Review 1.  The epipharynx-kidney axis triggers glomerular vasculitis in immunoglobulin A nephropathy.

Authors:  Osamu Hotta; Takashi Oda
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

2.  Human neutrophils are targets to paracoccin, a lectin expressed by Paracoccidioides brasiliensis.

Authors:  R Ricci-Azevedo; R A Gonçales; M C Roque-Barreira; D Girard
Journal:  Inflamm Res       Date:  2017-10-10       Impact factor: 4.575

3.  Neutrophil Mechanosignaling Promotes Integrin Engagement With Endothelial Cells and Motility Within Inflamed Vessels.

Authors:  Vasilios A Morikis; Scott I Simon
Journal:  Front Immunol       Date:  2018-11-28       Impact factor: 7.561

4.  Mechanical features of endothelium regulate cell adhesive molecule-induced calcium response in neutrophils.

Authors:  Yanhong Xu; Dandan Huang; Shouqin Lü; Yan Zhang; Mian Long
Journal:  APL Bioeng       Date:  2019-03-28

5.  The P-selectin and PSGL-1 axis accelerates atherosclerosis via activation of dendritic cells by the TLR4 signaling pathway.

Authors:  Zhishuai Ye; Lei Zhong; Shengnan Zhu; Yinuo Wang; Jie Zheng; Shujing Wang; Jianing Zhang; Rongchong Huang
Journal:  Cell Death Dis       Date:  2019-07-01       Impact factor: 8.469

Review 6.  Neutrophil signaling during myocardial infarction wound repair.

Authors:  Michael J Daseke; Upendra Chalise; Mediha Becirovic-Agic; Jeffrey D Salomon; Leah M Cook; Adam J Case; Merry L Lindsey
Journal:  Cell Signal       Date:  2020-10-24       Impact factor: 4.315

Review 7.  Endothelial cells, neutrophils and platelets: getting to the bottom of an inflammatory triangle.

Authors:  Tima Dehghani; Alyssa Panitch
Journal:  Open Biol       Date:  2020-10-14       Impact factor: 6.411

Review 8.  Role of Palatine Tonsil and Epipharyngeal Lymphoid Tissue in the Development of Glomerular Active Lesions (Glomerular vasculitis) in Immunoglobulin A Nephropathy.

Authors:  Osamu Hotta; Norio Ieiri; Masaaki Nagai; Ayaki Tanaka; Yasuaki Harabuchi
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.